A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

NCT07006792 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Lebrikizumab

Sponsor

Eli Lilly and Company